A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Sensex
77,537.72
▲ +0.82%
Nifty
24,231.85
▲ +0.64%
22k Gold
₹ 14,600/gm
Silver
₹ 2,55,000/kg
Petrol
₹ 111.21
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 94.42
USD
₹ 95.79
Sensex
77,537.72
▲ +0.82%
Nifty
24,231.85
▲ +0.64%
22k Gold
₹ 14,600/gm
Silver
₹ 2,55,000/kg
Petrol
₹ 111.21
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 94.42
USD
₹ 95.79
Nippon India Nifty Pharma ETF
3 Year Absolute Returns
74.45% ↑
NAV (₹) on 19 Aug 2026
27.06
1 Day NAV Change
-0.18%
Risk Level
Very High Risk
Rating
-
Nippon India Nifty Pharma ETF is a Equity mutual fund categorized under ETF, offered by Nippon Life India Asset Management Ltd.. Launched on 21 Jun 2021, investors can start with a lumpsum investment ... Read more
NAV History
Fund Details
Min. SIP Amount
N/A
Inception Date
21 Jun 2021
Min. Lumpsum Amount
₹ 1,000
Fund Age
5 Yrs
AUM
₹ 1,691.41 Cr.
Benchmark
Nifty Pharma Total Return
Expense Ratio
%
Scheme Type
Open Ended
Exit Load
Nil%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,691.41 Cr
Equity
99.78%
Money Market & Cash
0.02%
Other Assets & Liabilities
0.2%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 99.78% |
| Current Assets | 0.20% |
| Treps/Reverse Repo | 0.02% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 21.29% | ₹ 360.15 | Pharmaceuticals |
| Divi's Laboratories Limited | 10.34% | ₹ 174.96 | Pharmaceuticals |
| Cipla Limited | 8.37% | ₹ 141.65 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 7.59% | ₹ 128.39 | Pharmaceuticals |
| Laurus Labs Limited | 7.14% | ₹ 120.75 | Pharmaceuticals |
| Dr. Reddy's Laboratories Limited | 7.07% | ₹ 119.59 | Pharmaceuticals |
| Lupin Limited | 5.93% | ₹ 100.22 | Pharmaceuticals |
| Aurobindo Pharma Limited | 4.42% | ₹ 74.74 | Pharmaceuticals |
| Alkem Laboratories Limited | 3.40% | ₹ 57.51 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 3.40% | ₹ 57.48 | Pharmaceuticals |
| Biocon Limited | 3.07% | ₹ 51.90 | Pharmaceuticals |
| Zydus Lifesciences Limited | 2.85% | ₹ 48.17 | Pharmaceuticals |
| Mankind Pharma Limited | 2.82% | ₹ 47.78 | Pharmaceuticals |
| IPCA Laboratories Limited | 2.45% | ₹ 41.48 | Pharmaceuticals |
| Gland Pharma Limited | 2.02% | ₹ 34.08 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.83% | ₹ 31 | Pharmaceuticals |
| Wockhardt Limited | 1.63% | ₹ 27.65 | Pharmaceuticals |
| Ajanta Pharma Limited | 1.47% | ₹ 24.92 | Pharmaceuticals |
| Abbott India Limited | 1.46% | ₹ 24.76 | Pharmaceuticals |
| Piramal Pharma Limited | 1.23% | ₹ 20.79 | Pharmaceuticals |
| Net Current Assets | 0.20% | ₹ 3.05 | Others |
| Triparty Repo | 0.02% | ₹ 0.38 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 16.23% | 19.67% | 9.23% | 20.38% |
| Category returns | 0.84% | 5.27% | 4.58% | 21.88% |
Fund Objective
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject ... Read more
AMC Details
Name
Nippon Life India Asset Management Ltd.
Date of Incorporation
30 Jun 1995
CEO
Mr. Sundeep Sikka
CIO
Mr. Amit Tripathi Mr. Sailesh Raj Bhan
Type
Foreign
Address
4th Floor, Tower A,
Peninsula Business Park,
Ganapatrao Kadam Marg,
Lower Parel (W), Mumbai, Maharashtra, India - 400013
Website
https://www.nipponindiamf.com
Email
Top Funds from Others - Index Funds/ETFs
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
HDFC Silver ETF
ETF
Regular
|
₹217.03 | 97.77% | 216.22% | 0.00% | ₹7,473 | 0.50% |
Very High
|
|
Aditya Birla Sun Life Silver ETF
ETF
Regular
|
₹226.57 | 98.66% | 214.86% | 0.00% | ₹2,756 | 0.35% |
Very High
|
|
ICICI Prudential Silver ETF
ETF
Regular
|
₹226.51 | 98.83% | 214.24% | 0.00% | ₹13,701 | 0.40% |
Very High
|
|
Axis Silver ETF
ETF
Regular
|
₹225.57 | 98.24% | 214.21% | 0.00% | ₹1,855 | 0.42% |
Very High
|
|
Kotak Silver ETF
ETF
Regular
|
₹22.01 | 98.53% | 213.35% | 0.00% | ₹3,376 | 0.35% |
Very High
|
|
DSP Silver ETF
ETF
Regular
|
₹218.73 | 98.67% | 213.19% | 0.00% | ₹1,401 | N/A |
Very High
|
|
Mirae Asset Silver ETF
ETF
Regular
|
₹220.88 | 98.24% | 212.76% | 0.00% | ₹1,102 | 0.36% |
Very High
|
|
Nippon India Silver ETF
ETF
Regular
|
₹216.99 | 98.09% | 211.62% | 0.00% | ₹29,499 | N/A |
Very High
|
|
UTI Silver Exchange Traded Fund
ETF
Regular
|
₹219.07 | 96.69% | 208.54% | 0.00% | ₹1,358 | 0.59% |
Very High
|
|
Mirae Asset NYSE FANG + ETF
ETF
Regular
|
₹172.32 | 32.34% | 185.64% | 236.98% | ₹3,992 | 0.67% |
Very High
|
Top Funds from Nippon Life India Asset Management Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.02 | 134.17% | 299.70% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.02 | 134.17% | 299.70% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.02 | 134.17% | 299.70% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.66 | 131.03% | 283.50% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.66 | 131.03% | 283.50% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.66 | 131.03% | 283.50% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Silver ETF
ETF
Regular
|
₹216.99 | 98.09% | 211.62% | 0.00% | ₹29,499 | N/A |
Very High
|
|
Nippon India Silver ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹34.49 | 95.74% | 205.71% | 0.00% | ₹4,166 | 0.22% |
Very High
|
|
Nippon India Silver ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹34.49 | 95.74% | 205.71% | 0.00% | ₹4,166 | 0.22% |
Very High
|
|
Nippon India Silver ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹34.49 | 95.74% | 205.71% | 0.00% | ₹4,166 | 0.22% |
Very High
|
FAQs
What is the current NAV of Nippon India Nifty Pharma ETF Regular Growth?
The current Net Asset Value (NAV) of Nippon India Nifty Pharma ETF Regular Growth is ₹27.06 as of 19 Aug 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Nippon India Nifty Pharma ETF Regular Growth?
The Assets Under Management (AUM) of Nippon India Nifty Pharma ETF Regular Growth is ₹1,691.41 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Nippon India Nifty Pharma ETF Regular Growth?
Nippon India Nifty Pharma ETF Regular Growth has delivered returns of 19.67% (1 Year), 20.38% (3 Year), 13.90% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Nippon India Nifty Pharma ETF Regular Growth?
Nippon India Nifty Pharma ETF Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Nippon India Nifty Pharma ETF Regular Growth?
The minimum lumpsum investment required for Nippon India Nifty Pharma ETF Regular Growth is ₹1,000. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+